AUSTIN, Texas (AP) _ Aeglea Biotherapeutics Inc. (AGLE) on Tuesday reported a loss of $7.9 million in its third quarter.
The Austin, Texas-based company said it had a loss of 48 cents per share.
The biopharmaceutical company posted revenue of $1.3 million in the period.
In the final minutes of trading on Tuesday, the company's shares hit $4.85. A year ago, they were trading at $6.08.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGLE at https://www.zacks.com/ap/AGLE